Aeluma CHIPS LOI and Sumitomo expansion add headline catalysts, but financials still lack commercial traction

What happened

Aeluma announced fourth quarter and full fiscal year 2026 results, signed a non-binding Letter of Intent for up to $30 million under the CHIPS program for AI and advanced computing, and executed a new strategic agreement with Sumitomo Chemical Advanced Technologies to expand the relationship and increase wafer capacity. The prior DeepValue report rated ALMU a POTENTIAL SELL at $31.50, arguing that the valuation embeds a rapid AI datacom commercialization inflection unsupported by filings showing revenue as primarily from R&D contracts and delayed government program starts. The CHIPS LOI is a government-oriented funding signal, not confirmed commercial product revenue, and the Sumitomo agreement expands manufacturing capacity without yet demonstrating customer pull-through or production qualification milestones. Financial results for Q4 and FY2026 were not detailed in the release excerpt, but prior guidance of $4.2-$4.6 million revenue and Q3 revenue of $1.2 million (primarily R&D) suggest the business remains pre-scale and dependent on contract timing. Until the company discloses a meaningful shift in revenue mix toward commercial orders, avoids using the $50 million ATM before demonstrating production qualification, and converts the LOI into an executed award, the investment thesis remains unchanged.

Implication

Investors should treat today's announcements as incremental positive signals rather than a thesis-changing event. The CHIPS LOI is non-binding and may not convert into funding; even if it does, it is government support tied to advanced computing, not evidence of commercial AI datacom orders. The Sumitomo agreement to increase wafer capacity is operationally important but does not by itself create demand or revenue. The core bear case remains intact: FY26 revenue likely finished near the low end of guidance, customer concentration remains extreme, and the $50 million ATM is an overhang if used before product qualification. Maintain the POTENTIAL SELL rating and require proof of non-government revenue growth and no ATM sales before reconsidering.

Thesis delta

The signed CHIPS LOI for up to $30 million and expanded Sumitomo agreement are incremental positive developments but do not alter the core thesis that ALMU remains R&D-heavy with no disclosed commercial purchase orders. The LOI is non-binding and government-oriented, while capacity expansion still requires customer orders to generate revenue. Master rating POTENTIAL SELL remains intact; key checkpoints are unchanged: revenue mix must shift away from R&D contracts and ATM sales should not occur before production qualification milestones.